[ccpw id="5"]

Home.forex news report“The Opportunities Are Better Elsewhere”

“The Opportunities Are Better Elsewhere”

-


Nebius Group N.V. (NASDAQ:NBIS) is one of the stocks Jim Cramer talked about. A caller inquired about Cramer’s thoughts on the company in the “year of practical investing.” In response, Cramer commented:

“Well, I’ll tell you, a younger person came to me, asked me about stocks that were losing money the other night… And I said to him, losing too much money, and I said, you’re young, you can speculate on it. A person who’s a little bit older, too much risk to it. But I blessed it for him because he’s very young. Otherwise, no, the opportunities are better elsewhere.”

Stock market reports printed on a sheet of paper. Photo by RDNE Stock Project on Pexels

Nebius Group N.V. (NASDAQ:NBIS) provides AI-focused infrastructure, including GPU-based cloud platforms and tools that support the development of advanced models. During the lightning round of November 19, 2025, episode, a caller asked about the stock and Cramer said in response:

“Okay, Nebius is too speculative for me. It’s losing money. Why not just go with Dell? Dell’s a terrific company. The stock is down very big. Buy some now, buy some after the earnings, and I think you’ll be in terrific shape.”

While we acknowledge the potential of NBIS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance

Indivior PLC (NASDAQ:INDV) is one of the best performing pharma stocks in 2025. Indivior PLC (NASDAQ:INDV) announced its full-year 2026 financial...

FX Watch: USD/JPY and AUD/USD’s Setups if U.S. CPI Encourages Aggressive Fed Rate Cuts

Will U.S. dollar bears make a comeback as Uncle Sam rolls out its latest inflation updates? Our Event Guide for the U.S. CPI report points...

Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the price...

Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights

Amarin Corporation plc (NASDAQ:AMRN) is one of the best performing pharma stocks in 2025. Amarin Corporation plc (NASDAQ:AMRN) announced select unaudited...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img